Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support
Circulation · 31.01.2023 · 147 (5) · 409-424
DOI: 10.1161/circulationaha.121.056600 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 31.01.2023. Verfasst von Stavros G Drakos und 22 weiteren Autor:innen. Beteiligte Einrichtung: Nora Eccles Harrison Cardiovascular Research and Training Institute (S.G.D., R.B., A.M., C.P.K., O.W.-P., C.M.T., A.B., R.B., I.T., D.K.A.R., S.N., E…. Hauptthemen laut MEDLINE: Heart Transplantation, Heart Failure, Heart-Assist Devices. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Extensive evidence from single-center studies indicates that a subset of patients with chronic advanced heart failure (HF) undergoing left ventricular assist device (LVAD) support show significantly improved heart function and reverse structural remodeling (ie, termed “responders”). Furthermore, we recently published a multicenter prospective study, RESTAGE-HF (Remission from Stage D Heart Failure), demonstrating that LVAD support combined with standard HF medications induced remarkable cardiac structural and functional improvement, leading to high rates of LVAD weaning and excellent long-term outcomes. This intriguing phenomenon provides great translational and clinical promise, although the underlying molecular mechanisms driving this recovery are largely unknown.
Methods
To identify changes in signaling pathways operative in the normal and failing human heart and to molecularly characterize patients who respond favorably to LVAD unloading, we performed global RNA sequencing and phosphopeptide profiling of left ventricular tissue from 93 patients with HF undergoing LVAD implantation (25 responders and 68 nonresponders) and 12 nonfailing donor hearts. Patients were prospectively monitored through echocardiography to characterize their myocardial structure and function and identify responders and nonresponders.
Results
These analyses identified 1341 transcripts and 288 phosphopeptides that are differentially regulated in cardiac tissue from nonfailing control samples and patients with HF. In addition, these unbiased molecular profiles identified a unique signature of 29 transcripts and 93 phosphopeptides in patients with HF that distinguished responders after LVAD unloading. Further analyses of these macromolecules highlighted differential regulation in 2 key pathways: cell cycle regulation and extracellular matrix/focal adhesions.
Conclusions
This is the first study to characterize changes in the nonfailing and failing human heart by integrating multiple -omics platforms to identify molecular indices defining patients capable of myocardial recovery. These findings may guide patient selection for advanced HF therapies and identify new HF therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nora Eccles Harrison Cardiovascular Research and Training Institute (S.G.D., R.B., A.M., C.P.K., O.W.-P., C.M.T., A.B., R.B., I.T., D.K.A.R., S.N., E.T., T.S.S., J.V., R.H., E.L.S., C.H.S., S.F.), University of Utah, Sa…
- Utah Transplantation Affiliated Hospitals Cardiac Transplant Program (University of Utah, Intermountain Medical Center, Salt Lake VA Medical Center), (S.G.D., C.P.K., O.W.-P., I.T., E.D., T.C.H., E.T., E.L.S., W.T.C., R…
- Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City (S.G.D., C.P.K., O.W.-P., I.T., E.D., T.C.H., E.T., S.F.).
- Bioinformatics Core, Huntsman Cancer Institute (T.P.), University of Utah, Salt Lake City.
ORCID-Profile: Stavros G Drakos, Aman Makaju, Christos P Kyriakopoulos, Omar Wever-Pinzon, Anna Bakhtina, Ryan Bia, Timothy Parnell, Iosif Taleb, Dinesh K A Ramadurai, Thomas C Hanff, Thirupura S Shankar, Joseph Visker, William T Caine, Craig H Selzman, Sarah Franklin
Förderung
- NCATS NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- CSRD VA
- NCI NIH HHS
Zitieren
APA
Drakos, S. G., Badolia, R., Makaju, A., Kyriakopoulos, C. P., Wever-Pinzon, O., Tracy, C. M., Bakhtina, A., Bia, R., Parnell, T., Taleb, I., Ramadurai, D. K. A., Navankasattusas, S., Dranow, E., Hanff, T. C., Tseliou, E., Shankar, T. S., Visker, J., Hamouche, R., Stauder, E. L., …, & Franklin, S. (2023). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424. https://doi.org/10.1161/circulationaha.121.056600
Vancouver
Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, et al. Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation. 2023;147(5):409-424. doi:10.1161/circulationaha.121.056600
BibTeX
@article{Drakos2023,
author = {Drakos, Stavros G and Badolia, Rachit and Makaju, Aman and Kyriakopoulos, Christos P and Wever-Pinzon, Omar and Tracy, Christopher M and Bakhtina, Anna and Bia, Ryan and Parnell, Timothy and Taleb, Iosif and Ramadurai, Dinesh K A and Navankasattusas, Sutip and Dranow, Elizabeth and Hanff, Thomas C and Tseliou, Eleni and Shankar, Thirupura S and Visker, Joseph and Hamouche, Rana and Stauder, Elizabeth L and Caine, William T and Alharethi, Rami and Selzman, Craig H and Franklin, Sarah},
title = {Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support},
journal = {Circulation},
year = {2023},
volume = {147},
number = {5},
pages = {409--424},
doi = {10.1161/circulationaha.121.056600}
}
EUVIMED